On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
All content for Brains Behind AI is the property of Ari Yacobi and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
CoRead AI: Dr. Ngo on AI algorithms to monitor for known radiologist blind-spots
Brains Behind AI
39 minutes
3 years ago
CoRead AI: Dr. Ngo on AI algorithms to monitor for known radiologist blind-spots
On this episode of “Brains Behind AI”, Ari had the opportunity to speak with Lawrence Ngo, a practicing radiologist with a PhD in neurobiology. Lawrence is also the Co-founder and CEO of CoRead.AI, a start-up that has developed machine learning algorithms that analyzes the images and reports from radiology exams, and flags studies with high probability for peer review. We dive into Dr. Ngo’s ride from earning his PhD, working through his residency, and founding an AI company. CoRead AI been a...
Brains Behind AI
On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
